MD-14 import license process, CDSCO medical device import license, and MD-14 application for US manufacturers are the most searched terms right now as American companies rush to tap into India’s $50 billion medical device market by 2030. Whether you are exporting diagnostic kits, implants, or high-tech equipment from the US, securing the MD-14 license is the mandatory gateway under the Medical Devices Rules, 2017. Without it, your shipments will be stuck at customs, and your Indian distributor cannot legally sell a single unit.
This comprehensive 2026 guide walks you through the entire MD-14 process step by step, with a complete real-world example of a US company successfully importing a Class C cardiac stent. You will learn exact documents required, SUGAM portal navigation, fees, timelines, common rejection reasons, and post-approval compliance — everything you need to avoid costly delays. By the end, you will understand why partnering with an experienced Authorized Indian Agent can cut your approval time from 9 months to under 5 months.
Why MD-14 Is Non-Negotiable for US Exporters
India now classifies all medical devices (Class A to D) under the Drugs and Cosmetics Act. Foreign manufacturers cannot apply directly. You must appoint an Authorized Indian Agent (IAA) who holds a valid MD-42 wholesale license or manufacturing license. The IAA submits Form MD-14 on your behalf through the CDSCO’s online SUGAM portal. Once approved, CDSCO issues Form MD-15 — the actual import license that is valid for five years (subject to retention fees).
Missing even one document or making a classification error can lead to queries that add 3–6 months. That is why hundreds of US firms lose valuable market time every year.
Step-by-Step MD-14 Import License Process (2026)
Step 1: Device Classification & Strategy Planning (1–2 weeks) Classify your product using CDSCO’s official list or the IMDRF risk-based system.
- Class A (low risk) – fastest approval
- Class B (low-moderate)
- Class C (moderate-high) – most US implants fall here
- Class D (high risk) – longest scrutiny
Decide whether you need a single-device or multiple-device application. Prepare a regulatory strategy: leverage your US FDA 510(k) or PMA as supporting evidence to speed up review.
Step 2: Appoint a Compliant Authorized Indian Agent (IAA) The IAA must be an Indian company with:
- Valid MD-42 wholesale license
- Power of Attorney from your US firm (notarized & apostilled)
- ISO 13485 certified storage & distribution facility
The IAA becomes your legal face in India and handles all CDSCO communication.
Step 3: Register on SUGAM Portal & Create Application
- Both manufacturer and IAA register on cdsco.gov.in/sugam
- Log in → Medical Devices → Import License → New Application → Form MD-14
- Select device class and fill basic details (manufacturer name, address, device nomenclature, GMDN code)
Step 4: Prepare & Upload the Complete Technical Dossier This is the heart of MD-14. You must upload in PDF format (max 5 MB per file):
- Covering letter on IAA letterhead
- Form MD-14 (auto-generated by SUGAM)
- Power of Attorney (apostilled)
- Free Sale Certificate from US FDA (or home country)
- ISO 13485 certificate of manufacturing site
- Plant Master File (PMF)
- Device Master File (DMF) – design, specifications, labeling, IFU
- Clinical evaluation report / literature review
- Sterilization validation (if applicable)
- Biocompatibility & toxicological data
- Risk management file (ISO 14971)
- Stability & shelf-life data
- Labeling & packaging details (must meet Indian rules)
- US FDA clearance/approval copy
- Undertaking on Form MD-14 that device is not banned in India
Step 5: Pay the Prescribed Fee
- Class A/B: ₹50,000 per device + ₹1,000 per additional site
- Class C/D: ₹1,00,000 per device + ₹2,000 per additional site Payment is online via SUGAM (net banking or card).
Step 6: Submit & Track Application After uploading and payment, click “Submit”. You receive an application number (e.g., MD/IMP/2026/XXXX). CDSCO assigns a reviewer within 7–15 days.
Step 7: Respond to Queries (If Any) 90% of applications receive queries. Common ones:
- Missing biocompatibility data
- Incomplete labeling in English + Hindi
- Clarification on shelf life
- Site inspection request for Class C/D
You get 30–90 days to reply via SUGAM. Fast, complete responses shorten approval dramatically.
Step 8: Site Inspection (For Class C & D) CDSCO may inspect your US manufacturing facility or accept FDA inspection reports under mutual recognition. The IAA’s warehouse is always inspected.
Step 9: Grant of MD-15 Import License Once satisfied, CDSCO issues Form MD-15 digitally. You can now import commercially. The license is valid for 5 years; pay retention fee every 5 years.
Step 10: Post-Approval Compliance
- Import only approved devices
- Maintain import records for 5 years
- Report adverse events within 15 days
- Renewal or change notification via Form MD-26
Full Real-World Example: US Company “CardioMed Inc.” Imports Class C Cardiac Stent
Company: CardioMed Inc., California (FDA 510(k) cleared stent) Device: Drug-Eluting Coronary Stent System (Class C) IAA: Delhi-based regulatory firm with MD-42 license
Timeline & Documents Submitted (March–July 2025):
- March 10: Signed Power of Attorney + ISO 13485 uploaded
- March 15: Free Sale Certificate from FDA apostilled
- March 20: Complete DMF + clinical data (300+ pages)
- March 25: Paid ₹1,00,000 fee
- April 5: Application submitted (MD/IMP/2025/4782)
- April 28: Received 7 queries (biocompatibility, labeling)
- May 15: Queries replied with additional studies
- June 10: CDSCO inspected IAA warehouse in Noida
- June 25: Site inspection report cleared
- July 12: MD-15 license granted (valid till July 2030)
Total time: 119 days(Average), First shipment of 500 stents cleared customs within 48 hours of license receipt. Revenue from India in first year exceeded $2.4 million.
The same company later used the MD-15 to add two more sizes without a fresh full application — only a variation filing.
Common Pitfalls US Manufacturers Face (And How to Avoid Them)
- Using an IAA without MD-42 license → immediate rejection
- Submitting untranslated labeling → 60-day delay
- Missing GMDN code → query loop
- Poorly prepared clinical evaluation report → rejection
Pro tip: Start document preparation 3 months before submission. Use a regulatory consultant who has filed 50+ MD-14 applications.
Benefits of Getting MD-14 Right the First Time
- Legal nationwide sales through any distributor
- Faster customs clearance (no repeated Form 10/11 issues)
- Ability to advertise and exhibit at Indian medical expos
- Stronger valuation if you plan to set up local manufacturing later
With India’s medical device market growing 15% annually, companies that secure MD-14 early capture first-mover advantage against Chinese competitors.
Ready to File Your MD-14? Get Expert Help Today
Navigating the MD-14 import license process can feel overwhelming, but you don’t have to do it alone. Our Delhi-based team specializes in end-to-end CDSCO compliance for US manufacturers. We handle everything from IAA appointment and dossier preparation to query responses and post-license support.
Contact Us for Personalized MD-14 Assistance 📍 Delhi, India (NCR) 📧 Email: [email protected] 📞 Call/WhatsApp: +91-8920964801🌐 Website: www.medicaldeviceregistration.in
We offer: • Free device classification & strategy call • Fixed-fee MD-14 filing packages • 100% money-back if license not granted (conditions apply) • Same-day SUGAM registration support
Hundreds of US companies — from startups to Fortune 500 med-tech giants — have successfully entered India with our help. Whether your product is Class B infusion pumps or Class D MRI coils, we guarantee faster approval and zero compliance headaches.
Don’t let paperwork delay your India launch. Schedule your free 30-minute consultation today and turn the MD-14 process into your competitive advantage.
By Satis Mehra Follow us on X @realnewshubs and subscribe for push notifications